Association Between Uric Acid to HDL Cholesterol Ratio and Diabetic Complications in Men and Postmenopausal Women

Aim Previous studies have implicated the uric acid to high-density lipoprotein cholesterol (HDL-C) ratio (UHR) was associated with type 2 diabetes. However, the association between UHR and diabetes-related vascular damages is still unclear. Methods The total of 4551 patients with type 2 diabetes from the cross-sectional Environmental Pollutant Exposure and Metabolic Diseases in Shanghai study (METAL study) were enrolled. UHR was calculated as uric acid to HDL-C ratio. Cardiovascular disease (CVD) was defined as previously diagnosed with stroke, coronary heart disease, or peripheral arterial disease. Chronic kidney disease (CKD) was defined as estimated glomerular filtration rate ≤60 mL/min/1.73 m2 and/or urinary albumin to creatinine ratio ≥30 mg/g. Fundus image was examined by trained individuals and degree of diabetic retinopathy (DR) was evaluated. Results UHR was positively correlated with CVD (OR = 1.28, 95% CI: 1.02–1.61) and CKD (OR = 1.78, 95% CI: 1.39–2.27) after adjusting for all confounders. No association was found between UHR and DR. In stratified analyses, UHR was predominantly correlated with CVD in diabetic patients with age older than 65 (OR = 1.41, 95% CI: 1.08–1.85), female (OR = 1.43, 95% CI: 1.06–1.94) and BMI≥24kg/m2 (OR = 1.57, 95% CI: 1.17–2.11). A 1-SD increment of UHR was also positively associated with CVD (OR 1.26, 95% CI 1.03, 1.15) and CKD (OR 1.28, 95% CI 1.20,1.39). UHR was positively associated with CKD in all subgroups analysis. No significant interaction effect was observed between UHR and all subgroup variables in CVD and CKD risk. Conclusion Our study reported a positive association between the UHR and diabetic-related vascular complications in men and postmenopausal women. The relationship between the UHR and DR seems to be uncertain and requires further investigation. And no significant interaction effect was observed between the UHR and all subgroup variables in CVD and CKD risk.

[1]  Y. Gunes,et al.  Poorly controlled hypertension is associated with elevated serum uric acid to HDL-cholesterol ratio: a cross-sectional cohort study , 2022, Postgraduate medicine.

[2]  A. Baniasad,et al.  Investigating the relationship between serum uric acid to high‐density lipoprotein ratio and metabolic syndrome , 2021, Endocrinology, diabetes & metabolism.

[3]  Yingli Lu,et al.  Moderation effect of economic status in the association between early life famine exposure and MAFLD in adulthood , 2021, Liver international : official journal of the International Association for the Study of the Liver.

[4]  Min Chen,et al.  Association between serum uric acid level and mortality in China , 2021, Chinese medical journal.

[5]  G. Aktas,et al.  Hashimoto’s thyroiditis is associated with elevated serum uric acid to high density lipoprotein-cholesterol ratio , 2021, Romanian journal of internal medicine = Revue roumaine de medecine interne.

[6]  A. Pan,et al.  Epidemiology and determinants of obesity in China. , 2021, The lancet. Diabetes & endocrinology.

[7]  G. Aktas,et al.  The association between serum uric acid to high density lipoprotein-cholesterol ratio and non-alcoholic fatty liver disease: the abund study. , 2021, Revista da Associacao Medica Brasileira.

[8]  S. Musani,et al.  Metabolic Dyslipidemia and Cardiovascular Outcomes in Type 2 Diabetes Mellitus: Findings From the Look AHEAD Study , 2021, Journal of the American Heart Association.

[9]  D. Mikhailidis,et al.  Serum uric acid and diabetes: from pathophysiology to cardiovascular disease. , 2021, Current pharmaceutical design.

[10]  Y. Liu,et al.  Associations of serum uric acid and urinary albumin with the severity of diabetic retinopathy in individuals with type 2 diabetes , 2020, BMC Ophthalmology.

[11]  E. Ferrannini,et al.  Early Signs of Atherogenic Features in the HDL Lipidomes of Normolipidemic Patients Newly Diagnosed with Type 2 Diabetes , 2020, International journal of molecular sciences.

[12]  R. Estruch,et al.  Dietary Strategies for Metabolic Syndrome: A Comprehensive Review , 2020, Nutrients.

[13]  Yingli Lu,et al.  Associations between abdominal obesity indices and diabetic complications: Chinese visceral adiposity index and neck circumference , 2020, Cardiovascular Diabetology.

[14]  Yu Xu,et al.  Early life famine exposure, adulthood obesity patterns and the risk of nonalcoholic fatty liver disease , 2020, Liver international : official journal of the International Association for the Study of the Liver.

[15]  Yishu Chen,et al.  Association between Serum Uric Acid to HDL-Cholesterol Ratio and Nonalcoholic Fatty Liver Disease in Lean Chinese Adults , 2020, International journal of endocrinology.

[16]  G. Aktas,et al.  Is Neuregulin‐4 a predictive marker of microvascular complications in type 2 diabetes mellitus? , 2020, European journal of clinical investigation.

[17]  Yingli Lu,et al.  Different associations between serum urate and diabetic complications in men and postmenopausal women. , 2020, Diabetes research and clinical practice.

[18]  G. Hindricks,et al.  2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. , 2019, Atherosclerosis.

[19]  G. Aktas,et al.  Neuregulin-4 is associated with plasma glucose and increased risk of type 2 diabetes mellitus. , 2019, Swiss medical weekly.

[20]  G. Aktas,et al.  Uric acid to HDL cholesterol ratio is a strong predictor of diabetic control in men with type 2 diabetes mellitus , 2019, The aging male : the official journal of the International Society for the Study of the Aging Male.

[21]  M. Kocak,et al.  Serum uric acid to HDL-cholesterol ratio is a strong predictor of metabolic syndrome in type 2 diabetes mellitus. , 2019, Revista da Associacao Medica Brasileira.

[22]  C. Nam,et al.  Age-differential association between serum uric acid and incident hypertension , 2018, Hypertension Research.

[23]  G. Ndrepepa.  Uric acid and cardiovascular disease. , 2018, Clinica chimica acta; international journal of clinical chemistry.

[24]  L. Ji,et al.  The association of smoking and risk of diabetic retinopathy in patients with type 1 and type 2 diabetes: a meta-analysis , 2018, Endocrine.

[25]  S. Nicholls,et al.  The Role of High-Density Lipoproteins in Diabetes and Its Vascular Complications , 2018, International journal of molecular sciences.

[26]  J. Shaw,et al.  IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. , 2018, Diabetes research and clinical practice.

[27]  M. Doumas,et al.  Diabetes and lipid metabolism , 2018, Hormones.

[28]  Frank B. Hu,et al.  Global aetiology and epidemiology of type 2 diabetes mellitus and its complications , 2018, Nature Reviews Endocrinology.

[29]  J. Blacher,et al.  eGFRs from Asian-modified CKD-EPI and Chinese-modified CKD-EPI equations were associated better with hypertensive target organ damage in the community-dwelling elderly Chinese: the Northern Shanghai Study , 2017, Clinical interventions in aging.

[30]  H. Campbell,et al.  Serum uric acid levels and multiple health outcomes: umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studies , 2017, British Medical Journal.

[31]  Yingli Lu,et al.  Exacerbation of liver steatosis following exposure to famine and overnutrition. , 2017, Molecular nutrition & food research.

[32]  Lulu Chen,et al.  Elevated circulating Neuregulin4 level in patients with diabetes , 2017, Diabetes/metabolism research and reviews.

[33]  Sheridan M. Hoy.  Pitavastatin: A Review in Hypercholesterolemia , 2017, American Journal of Cardiovascular Drugs.

[34]  Carol L Cheatham,et al.  Blueberry Consumption Affects Serum Uric Acid Concentrations in Older Adults in a Sex-Specific Manner , 2016, Antioxidants.

[35]  D. Cucinotta,et al.  Plasma Triglycerides and HDL-C Levels Predict the Development of Diabetic Kidney Disease in Subjects With Type 2 Diabetes: The AMD Annals Initiative , 2016, Diabetes Care.

[36]  M. Blaha,et al.  Primary Low Level of High-Density Lipoprotein Cholesterol and Risks of Coronary Heart Disease, Cardiovascular Disease, and Death: Results From the Multi-Ethnic Study of Atherosclerosis. , 2016, American journal of epidemiology.

[37]  M. Jensen,et al.  Exposure to Famine in Early Life and Nonalcoholic Fatty Liver Disease in Adulthood. , 2016, The Journal of clinical endocrinology and metabolism.

[38]  G. Russo,et al.  Serum Uric Acid and Risk of CKD in Type 2 Diabetes. , 2015, Clinical journal of the American Society of Nephrology : CJASN.

[39]  Bing Zhang,et al.  The prevalence and secular trends of abdominal obesity among Chinese adults, 1993-2011. , 2015, Annals of epidemiology.

[40]  L. Afonso,et al.  Uric acid and cardiovascular disease risk reclassification: Findings from NHANES III , 2015, European journal of preventive cardiology.

[41]  J. Gamble,et al.  Comparative cardiovascular morbidity and mortality in patients taking different insulin regimens for type 2 diabetes: a systematic review , 2015, BMJ Open.

[42]  A. Esteghamati,et al.  Metabolic syndrome in premenopausal and postmenopausal women with type 2 diabetes: loss of protective effects of premenopausal status , 2014, Journal of Diabetes & Metabolic Disorders.

[43]  J. Blacher,et al.  Serum uric acid and cardiovascular risk: state of the art and perspectives. , 2014, Joint, bone, spine : revue du rhumatisme.

[44]  D. Rader,et al.  HDL and cardiovascular disease , 2014, The Lancet.

[45]  Lihteh Wu,et al.  Classification of diabetic retinopathy and diabetic macular edema. , 2013, World journal of diabetes.

[46]  Chong Shen,et al.  Hyperuricemia as an Independent Predictor of Vascular Complications and Mortality in Type 2 Diabetes Patients: A Meta-Analysis , 2013, PloS one.

[47]  Jiang He,et al.  Prevalence and control of diabetes in Chinese adults. , 2013, JAMA.

[48]  Davide Grassi,et al.  Send Orders of Reprints at Reprints@benthamscience.net Chronic Hyperuricemia, Uric Acid Deposit and Cardiovascular Risk , 2022 .

[49]  Allison L. Hopkins,et al.  Hibiscus sabdariffa L. in the treatment of hypertension and hyperlipidemia: a comprehensive review of animal and human studies. , 2013, Fitoterapia.

[50]  E. Boyko,et al.  Effects of menopause and hormone replacement therapy on the associations of hyperuricemia with mortality. , 2013, Atherosclerosis.

[51]  M. Woodward,et al.  Low HDL Cholesterol and the Risk of Diabetic Nephropathy and Retinopathy , 2012, Diabetes Care.

[52]  Z. Valenta,et al.  Natural postmenopause is associated with an increase in combined cardiovascular risk factors. , 2012, Physiological research.